! Not medical advice. Consult a doctor.

Reslizumab (Cinqair) Overview: Benefits, Side Effects | Curex

Explore the latest in allergy relief with our review of Reslizumab (Cinqair). We cover its effectiveness, side effects, and how it compares to other treatments. Perfect for those seeking a comprehensive overview in a concise format.
#1 Online
Allergy Clinic
 curex user showing allergy treatment kita patient showing allergy treatment boxa male patient showing allergy drops vial
50,000+
users

Reslizumab (Cinqair) Overview: Category & Primary Use

 

Reslizumab, marketed under the name Cinqair, is a medication classified as a monoclonal antibody. It is an interleukin-5 (IL-5) antagonist, which specifically targets and mitigates the effects of IL-5, a cytokine responsible for the growth, differentiation, recruitment, activation, and survival of eosinophils. By inhibiting IL-5, Reslizumab plays a pivotal role in controlling conditions associated with high levels of eosinophils.

 

Drug Category

 

  • Monoclonal Antibody
  • Interleukin-5 Antagonist
  • Biologic Agent

 

What it is Used For

 

Reslizumab is primarily used as an add-on maintenance therapy. This means it is not a standalone treatment but is used in conjunction with other medications to manage certain conditions more effectively.

 

  • Specifically prescribed for patients with severe asthma, reslizumab is administered in situations where traditional treatments are insufficient.
  • It is a vital therapy option for patients with a particular phenotype of asthma characterized by elevated eosinophil levels, often referred to as eosinophilic asthma.

 

What it Treats

 

The primary condition treated by Reslizumab is severe eosinophilic asthma. Patients with this type of asthma experience chronic inflammation in their airways due to an overabundance of eosinophils, leading to frequent and severe asthma attacks. Reslizumab helps to:

 

  • Reduce the frequency and severity of asthma exacerbations.
  • Improve lung function by decreasing the eosinophilic inflammation in the airways.
  • Enhance overall asthma control, thereby improving the quality of life for patients suffering from this severe form of asthma.

 

Why settle for temporary relief? Try immunotherapy for lasting results!

Am I eligible?

What Conditions Does Reslizumab (Cinqair) Treat?

 

Reslizumab, marketed as Cinqair, is a medication primarily used to treat certain conditions related to eosinophilic asthma. It is tailored for a specific subset of asthma patients whose symptoms are not adequately controlled with conventional treatments. Below are the key conditions that Reslizumab addresses.

 

Severe Eosinophilic Asthma

 

  • Eosinophilic Asthma: Specifically targets severe eosinophilic asthma, characterized by high levels of eosinophils (a type of white blood cell) in the airway, which contribute to inflammation and asthma symptoms.
  • Chronic Management: Used as an adjunctive therapy to improve asthma control and reduce the frequency of asthma exacerbations in patients 18 years of age and older.
  • Corticosteroid Dependency Reduction: Helps in reducing reliance on oral corticosteroids, which are otherwise required to manage severe respiratory symptoms.

 

Uncontrolled Asthma Symptoms

 

  • Recurrent Asthma Attacks: Aims at reducing the number of asthma attacks in patients experiencing recurrent exacerbations despite receiving standard asthma therapies.
  • Improved Lung Function: Contributes to better respiratory function and overall breathability by controlling airway inflammation.
  • Quality of Life Enhancement: Enhances the overall quality of life for individuals by mitigating severe asthma symptoms and improving daily functioning.

 

Reslizumab is specifically designed for patients whose asthma is not well-controlled with inhaled corticosteroids and other standard medications and is not meant for the treatment of other types of asthma or allergic conditions. Always consult with healthcare professionals prior to considering this treatment option to ensure its appropriateness for your specific medical condition.

 

Find out if immunotherapy is right for you

Reslizumab (Cinqair): Effectiveness and Advantages Overview

 

Introduction to Reslizumab (Cinqair)

 

  • Reslizumab is a monoclonal antibody used for the treatment of severe asthma with an eosinophilic phenotype, providing targeted therapeutic benefits.
  • Administered intravenously, it specifically binds to interleukin-5 (IL-5), reducing the inflammation associated with eosinophils.

 

Benefits of Reslizumab

 

  • Improved Asthma Control: By targeting and depleting eosinophils, Reslizumab effectively reduces asthma exacerbations, improving overall control.
  • Enhanced Quality of Life: Patients often experience fewer asthma-related disruptions, leading to a significant improvement in daily functioning and quality of life.
  • Reduction in Oral Corticosteroid Use: Many users report a decreased need for oral corticosteroids, minimizing potential side effects associated with long-term steroid use.
  • Tailored Therapy: Ideal for individuals with high eosinophil levels, ensuring that treatment is personalized and more effective for specific patient groups.

 

Supportive Evidence

 

  • Clinical trials have consistently demonstrated a reduction in asthma attacks and improved lung function in patients treated with Reslizumab.
  • Studies highlight its efficacy in patients aged 18 years and older, with significant improvements noted in pulmonary function tests.
  • The drug is generally well-tolerated, with a safety profile consistent across diverse demographic groups.

 

Conclusion

 

  • Reslizumab (Cinqair) stands as a progressive option for patients with eosinophilic asthma, offering targeted therapy that significantly enhances patient outcomes.
  • By reducing the eosinophilic burden, Reslizumab provides substantial therapeutic relief, aligning with the goals of personalized medicine in respiratory care.

 

Our team is here to help!

Dr. Neeta Ogden, MD

Curex is poised to revolutionize the way allergies are treated in America, expanding access to clinical care and treatments that can meaningfully improve patients quality of life.

Dr. Ravi Patel, VP Telemedicine

At Curex, our mission is to help people improve their health and quality of life by understanding their allergies and treating them at their source.We provide more than individualized prescription treatments; we provide individualized care.

Jill Hamburg, PA - C

Immunotherapy made simple.  We enable patients to receive personalized allergy care on their own time. No more waiting rooms.

Dr. Chet Tharpe, Medical Director

Curex has set the standard for the virtual allergy experience. From the comfort of their home, patients nationwide are able to receive a personalized treatment plan from an experienced clinician, aimed at treating the source of their allergies, not just the symptoms.

Kayla Mardaga, NP

Curex offers convenient at-home allergy testing options. Our goal is to determine if a patient would benefit from immunotherapy and then customize a treatment plan that can reduce both the symptoms and the reliance on allergy medications.

We love helping people!

Allie, Nevada

five stars

"I have two cats I can finally cuddle!"

Cat and dog allergies

Zachary, Texas

five stars

“I can breathe through my nose for the first time in like 20 years!"

dust allergy
mold allergy

Dust and mold allergies

Erika, New York

five stars

“I've noticed less sneezing and shortness of breath.”

tree allergy
grass allergy

Tree and grass allergies

Richard, Texas

five stars


I love the convenience!

tree allergy

Tree and cat allergies

Reslizumab (Cinqair) Side Effects: Common and Serious, When to Seek Help

 

Possible Side Effects of Reslizumab (Cinqair)

 

  • Injection Site Reactions: Pain, redness, or swelling at the site of injection may occur.
  • Oropharyngeal Pain: Some individuals might experience a sore throat.
  • Increased Risk of Infection: Potential to develop infections more easily, especially upper respiratory tract infections.
  • Muscle Pain: Patients may report general muscle discomfort.
  • Allergic Reactions: Includes symptoms like rash, itching, dizziness, or difficulty breathing.

 

Safety Precautions When Using Reslizumab (Cinqair)

 

  • Monitoring: Regular monitoring by a healthcare professional is essential to observe any adverse effects or allergic reactions.
  • Anaphylaxis Risk: Be aware of the potential for severe allergic reactions. Use under the supervision of a healthcare provider equipped to manage anaphylaxis.
  • Pre-existing Conditions: Inform your doctor about any existing issues such as parasitic infections or actual allergic conditions before starting therapy.
  • Pregnancy and Breastfeeding: Discuss the risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
  • Avoid Vaccinations: Live vaccines should be avoided during treatment without prior approval from your healthcare provider.

 

A safer solution to allergies: try immunotherapy today!

Advantages of Immunotherapy over Reslizumab (Cinqair)

 

When evaluating the merits of immunotherapy compared to Reslizumab (Cinqair) for allergy treatment, it's essential to consider the long-term implications, versatility, and the mechanism of action that underlie both treatments.

 

Mechanism of Action

 

  • Immunotherapy: Works by gradually desensitizing the immune system to allergens, which involves administering increasing doses of the allergen to build tolerance.
  • Reslizumab (Cinqair): This medication is a monoclonal antibody specifically targeting the interleukin-5 (IL-5) pathway to reduce eosinophil levels, widely used in severe asthma management caused by eosinophilic inflammation, but not specifically designed for general allergy treatment.

 

Scope of Treatment

 

  • Immunotherapy: Offers a broad-spectrum approach and is potentially effective for numerous allergens, including pollens, molds, and dust mites.
  • Reslizumab (Cinqair): Primarily focused on eosinophilic asthma and might not address the multitude of allergens that typical seasonal allergies encompass.

 

Long-term Outcomes

 

  • Immunotherapy: Aims to provide long-term relief and possibly alter the course of allergic disease, reducing the need for medications and improving quality of life.
  • Reslizumab (Cinqair): While effective for its scope, it does not modify the underlying allergic condition but rather alleviates the symptoms associated with eosinophilic inflammation.

 

Treatment Duration and Commitment

 

  • Immunotherapy: Requires commitment over a few years but can lead to lasting benefits even after treatment completion.
  • Reslizumab (Cinqair): Involves regular intravenous infusions that may continue for an indefinite period as part of managing asthma symptoms.

 

Potential Side Effects

 

  • Immunotherapy: Generally considered safe with side effects that are usually mild, such as local reactions at the injection site, though there is a risk of anaphylaxis.
  • Reslizumab (Cinqair): Potential side effects may include oropharyngeal pain, increased risk of infections, and possible hypersensitivity reactions.

 

Ultimately, the choice between immunotherapy and Reslizumab (Cinqair) should be guided by the patient's specific health needs, the nature of their allergic condition, and a thorough discussion with an allergist or healthcare provider.

 

PREVENTION+
Prevents allergies long term
At-home treatment saves time
Treatment taken daily under the tongue
Evaluation & allergy test at home
Talk or text with your clinician, as needed
$49/month (copays may apply)
ALLERGY SHOTS
Prevents allergies long term
Commute to clinic every week
Treatment injected weekly by syringe
Evaluation and testing in the clinic
Clinical visits require scheduling
Surprise insurance bills and high copays

We Treat Food, Indoor & Outdoor Allergies

tree allergy
Tree Pollens
maple leaf icon
Weed Pollens
Cat Allergies
Dog Allergies
insect icon
Dust Mites
mold allergy
Molds
Food Allergies

Benefits of Curex

At-home treatment

Apply treatments in minutes from the comfort of your own home with under-the-tongue applications instead of shots or pills

5-30x higher cumulative dose vs allergy shots

Sublingual immunotherapy delivers a higher dose of allergens over the course of treatment.

Potential for results in as few as 6 months

Individual results vary but some users have reported a noticeable difference in as few as 6-12 months since starting treatments

Excellent safety profile

Studies that have been reviewed by certified physicians show that sublingual immunotherapy is a safe treatment option
male medical practitioner smiling

Treatment prescribed
by clinician

1
right line icon
Curex packaging

Clinicaly made allergen extracts are customized for your allergies

2
right line icon
insect icon
grass icon
man opening Curex packaging

Your immune system gets desensitized to allergens, giving you long-term relief.

3

FAQs

Is Curex a legitimate telehealth service?
How much does it cost?
How long until I get the medication?
Is it safe to use at home?
What sets Curex apart from your local clinic?
Is the injection painful?
Will Dupixent work for me?
How long do I have to take Dupixent?
When can I stop taking other medications?
How to use the medication?
What’s the difference between an autoinjector and a pre-filled syringe?